Drger Receives Frost & Sullivan’s 2025 Global Company of the Year Recognition for Excellence in Respiratory Devices Innovation
Dräger recognized for pioneering innovations in respiratory care, delivering measurable improvements in…
ESHRE 41st Annual Meeting: Older paternal age linked to higher miscarriage risk and lower live birth rates in donor egg IVF cycles
A new international study presented today at the 41st Annual Meeting of…
KuCoin Futures Ranks 4th Globally on CoinGlass’ Latest Derivatives Exchange List
VICTORIA, Seychelles, July 3, 2025 /PRNewswire/ -- KuCoin, a leading global cryptocurrency…
CoinDesk Overnight Rates (CDOR) to Support Stablecoin Money Markets based on Aave
These first-of-kind money market rates transform Aave pool activity into conventional overnight…
KBRA Releases Research Private Credit: Business Development Company (BDC) Ratings Compendium: First-Quarter 2025
NEW YORK--(BUSINESS WIRE)--#creditratingagency--KBRA releases its Business Development Company Ratings Compendium, which looks…
Millimans first-ever Registered Index-Linked Annuity Experience Study shows behavior similarities with multi-year guaranteed annuity contract holders
Surrender rates skyrocket at the end of surrender charge periodSEATTLE--(BUSINESS WIRE)--#Annuities--Milliman, Inc.,…
Fibe Unveils Digital FDs, Strengthening Its Role as a One-Stop Financial Partner
Enables investments without a linked savings account, with options from top banks…
Manufacturers and Logistics Providers Embrace AI for Enhanced Barcode Reading Performance
Survey reveals 90% of users anticipate AI will improve accuracy, ease of…
Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with TE
Real-world claims studies evaluating UZEDY® (risperidone) also show improved adherence and persistence…
